Skip to main content
Dryad

Synergistic label-free fluorescence imaging and miRNA studies reveal dynamic human neuron-glial metabolic interactions following injury

Zhang, Yang1; Savvidou, Maria1; Liaudanskaya, Volha1; Singh, Pramesh1; Fu, Yuhang1; Nasreen, Amreen1; Coe, Marly1; Kelly, Marilyn1; Snapper, Dustin2; Wagner, Chelsea3; Gill, Jessica3; Symes, Aviva2; Patra, Abani1; Kaplan, David1; Beheshti, Afshin4; Georgakoudi, Irene1

Published Oct 18, 2024 on Dryad. https://doi.org/10.5061/dryad.b5mkkwhp5

Data files

Oct 18, 2024 version files 169.59 GB

Select up to 11 GB of files for download

Abstract

Neuron-glial cell interactions following traumatic brain injury (TBI) determine the propagation of damage and long-term neurodegeneration. Spatiotemporally heterogeneous cytosolic and mitochondrial metabolic pathways are involved, leading to challenges in developing effective diagnostics and treatments. An engineered 3D brain tissue model comprising human neurons, astrocytes, and microglia is used in combination with label-free, two-photon imaging and microRNA studies to characterize metabolic interactions between glial and neuronal cells over 72 hours following impact injury. We interpret multi-parametric, quantitative, optical metabolic assessments in the context of microRNA gene set analysis and identify distinct metabolic changes in neurons and glial cells. Glycolysis, NADPH and glutathione synthesis, fatty acid synthesis, and oxidation are mobilized within glial cells to mitigate the impacts of initial enhancements in oxidative phosphorylation and fatty acid oxidation within neurons, which lack robust anti-oxidant defenses. This platform enables enhanced understanding of mechanisms that may be targeted to improve TBI diagnosis and treatment.